SCHEMBL30299181

SCHEMBL30299181

O=C(O)c1ccncc1NCc1cccc(C(F)(F)F)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4C Q9H3R0 15/20 0.71
KDM5B Q9UGL1 2/20 0.71
KDM5A P29375 2/20 0.71
KDM6B O15054 5/20 0.68
KDM4E B2RXH2 3/20 0.68
KDM4A O75164 2/20 0.68
KDM4D Q6B0I6 2/20 0.68
AURKA O14965 1/20 0.54
RPS6KB1 P23443 1/20 0.54
AURKB Q96GD4 1/20 0.54
TRPV1 Q8NER1 1/20 0.53
RXFP1 Q9HBX9 1/20 0.53
KDM5C P41229 1/20 0.52
HDAC3 O15379 1/20 0.52
HDAC1 Q13547 1/20 0.52
HDAC2 Q92769 1/20 0.52
HDAC6 Q9UBN7 1/20 0.52
ASPH Q12797 1/20 0.52
RIOX2 Q8IUF8 1/20 0.52
KDM8 Q8N371 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15826507 1.00 KDM4C (0.71) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL15818834 0.87 KDM4C (0.61) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL30299208 0.85 KDM4C (0.71) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL15839874 0.85 KDM4C (0.71) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL15818434 0.84 KDM4C (0.73) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL15823547 0.83 KDM4C (1.00) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL30299270 0.83 KDM4C (1.00) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL15286282 0.81 KDM4C (1.00) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL15286568 0.79 KDM4C (0.69) KDM4CKDM5BKDM5AKDM6BKDM4E
SCHEMBL1714819 0.78 KDM4C (0.85) KDM4CKDM5BKDM6BKDM4EKDM4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230286917-A1 HISTONE DEMETHYLASE INHIBITORS CELGENE QUANTICEL RESEARCH, INC. (US) 2023-09-14 US disclosed
US-11639333-B2 Histone demethylase inhibitors CELGENE QUANTICEL RESEARCH, INC (US) 2023-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230286917-A1 HISTONE DEMETHYLASE INHIBITORS KDM1B, KDM5A, KDM1A KDM4C 18/4885KDM5B 6/4885KDM5A 2/4885
US-11639333-B2 Histone demethylase inhibitors KDM1B, KDM5A, KDM1A KDM4C 18/4885KDM5B 6/4885KDM5A 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.